JPRN-jRCT2080225346已完成2 期
Phase 2 Study of the Efficacy and Safety of Venetoclax in Combination with Ibrutinib in Japanese Subjects with Relapsed/Refractory Mantle Cell Lymphoma [M20-075]
未提供0 个研究点目标入组 12 人开始时间: 2020年8月25日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
2 期
Previously Untreated CLL and SLL: Safety and Efficacy of Venetoclax in Combination with Obinutuzumab or Ibrutinib in Japanese SubjectsJPRN-jRCT2021210055Okubo Sumiko20
进行中（未招募）
不适用
A phase 2a Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks with AuraMIgraine with auraEUCTR2009-010721-39-DKPeer Tfelt-Hansen
已完成
2 期
Phase II analysis for efficacy and safety of perioperative pirfenidone (Pirespa) therapy for patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)non-small-cell lung cancer combined with idiopathic pulmonary fibrosisJPRN-UMIN000007774West Japan Oncology Group42
已完成
2 期
A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers: REZOLVEACTRN12611000801910niversity of Sydney24
已完成
2 期
Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)JPRN-UMIN000020773Translational Research Informatics Center, Foundation for Biomedical Research and Innovation39